Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 16/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2223818 | 0.82 | HDAC1 (0.35) | HDAC4HDAC6HDAC8HDAC2HDAC1 | |
| SCHEMBL2224060 | 0.80 | HDAC4 (0.38) | HDAC4HDAC6HDAC8HDAC2HDAC1 | |
| SCHEMBL2224057 | 0.79 | HDAC4 (0.46) | HDAC4HDAC6HDAC8HDAC1HDAC7 | |
| SCHEMBL14603750 | 0.79 | HDAC4 (0.37) | HDAC4HDAC6HDAC8HDAC2HDAC1 | |
| SCHEMBL2223308 | 0.77 | HDAC4 (0.43) | HDAC4HDAC6HDAC8HDAC1HDAC7 | |
| SCHEMBL2221125 | 0.76 | HDAC4 (0.38) | HDAC4HDAC6HDAC8HDAC1HDAC7 | |
| SCHEMBL2220914 | 0.72 | SIGMAR1 (0.40) | — | |
| SCHEMBL6977627 | 0.71 | HDAC4 (0.63) | HDAC4HDAC6HDAC8HDAC2HDAC1 | |
| SCHEMBL2223878 | 0.70 | HDAC4 (0.37) | HDAC4HDAC6HDAC8HDAC1HDAC7 | |
| SCHEMBL2222441 | 0.69 | HDAC4 (0.37) | HDAC4HDAC6HDAC8HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013009812-A1 | METHODS OF TREATMENT | TEMPERO PHARMACEUTICALS, INC (US) | 2013-01-17 | — | — | WO | claimed |
| EP-2523560-A1 | COMPOUNDS AND METHODS | Tempero Pharmaceuticals, Inc. (US) | 2012-11-21 | — | — | EP | claimed |
| WO-2011088187-A1 | COMPOUNDS AND METHODS | TEMPERO PHARMACEUTICALS, INC. (US) | 2011-07-21 | — | — | WO | claimed |
| WO-2013009812-A1 | METHODS OF TREATMENT | TEMPERO PHARMACEUTICALS, INC (US) | 2013-01-17 | — | — | WO | disclosed |
| EP-2523560-A1 | COMPOUNDS AND METHODS | Tempero Pharmaceuticals, Inc. (US) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011088187-A1 | COMPOUNDS AND METHODS | TEMPERO PHARMACEUTICALS, INC. (US) | 2011-07-21 | — | — | WO | disclosed |